Complex Chest Wall Reconstruction Fri, Oct 9

Reconstruction of the sternum and chest wall defects will cover the entire gamut of disease processes that plastic surgeons are involved with. Patients who’ve had cardiac surgery and develop post-sternotomy mediastinitis are still at high risk of death.

The panel will cover treatment and prevention strategies of sternal complications as well as oncologic reconstruction of the sternum and chest wall.

Osteosynthesis to replacement strategies of the chest wall will be covered as well as function and long-term outcomes. Technical tips and pearls will also be shared in how to best treat this complex patient population.

At the end of this activity participants will be able to:

  1. Identify, diagnose and treat post-sternotomy mediastinitis, chest wall defects
  2. Understand the complexities of lung function after reconstruction and strategies for optimizing patient respiratory function and avoiding respiratory insufficiency.
  3. Discuss safe strategies for reconstruction of the thoracic wall as well as the overlying soft tissue.
  4. Discuss cutting edge and emerging technologies for chest wall reconstruction, including virtual surgical planning, 3D printing, and patient specific prosthetics.

Educational Grant Support Provided By: LEADERS: Allergan Aesthetics, an AbbVie Company; Galderma Laboratories, L.P.; Galatea Surgical, Inc.; INNOVATORS: Mentor Worldwide, LLC; SUPPORTERS: Johnson & Johnson Medical Devices Companies

In-Kind Support Provided By: Galatea Surgical, Inc.; Johnson & Johnson Medical Devices Companies

Accreditation: The American Society of Plastic Surgeons® (ASPS) is accredited by the Accreditation Council for Continuing Education to provide continuing medical education for physicians.

Designation: The ASPS designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.